文献速递肝病

在推测为代谢功能障碍相关脂肪性肝病的患者中,酒精相关肝病误分类常见且大幅增加未来肝硬化风险

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-01-17

瑞典1987至2020年注册队列纳入15107例MASLD患者,12%在基线前已有酒精相关肝病(ALD)或酒精使用障碍(AUD)诊断,随访中另有5.2%获得该诊断。基线前有ALD/AUD者主要不良肝脏结局(MALO)发生率为19.5%对7.8%,校正HR 3.12;MASLD诊断后新获ALD/AUD诊断者校正HR 5.81。

要点

  • 推测MASLD患者中12%在基线前已有ALD或AUD诊断,随访中5.2%新获该诊断。
  • 基线前有ALD/AUD者MALO发生率19.5%对7.8%,校正HR 3.12(95%CI 2.74-3.55)。
  • MASLD诊断后新获ALD/AUD诊断与MALO升高相关,校正HR 5.81(95%CI 4.90-6.88)。

核心结论

  • ALD或AUD在MASLD诊断前后均常见,此类患者进展至MALO的风险 considerably 更高。
  • 正确区分MASLD与ALD对评估预后至关重要。

研究设计与样本

  • 基于注册的队列研究,纳入瑞典1987至2020年间所有诊断为MASLD的患者。
  • 按MASLD诊断前是否共现ALD或AUD诊断进行分层,从国家注册数据库获取新发MALO。
  • 采用Cox回归计算新发MALO的风险比(HR)。

主要发现

  • 共识别15107例MASLD患者,中位年龄55岁,52%为女性。
  • 1843例(12%)在基线前已有ALD或AUD诊断,随访期间另有787例(5.2%)获得ALD或AUD诊断。
  • 基线时或基线前有ALD/AUD诊断者MALO发生率为19.5%,无此诊断者为7.8%;校正HR 3.12(95%CI 2.74-3.55)。
  • MASLD诊断后新获ALD/AUD诊断与MALO发生率升高相关,校正HR 5.81(95%CI 4.90-6.88)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Alcohol overconsumption is a risk factor for disease progression in patients with presumed metabolic dysfunction-associated steatotic liver disease (MASLD). How commonly this occurs and how it affects progression to major adverse liver outcomes (MALOs) is not well known. METHODS: We did a register-based cohort study, including all patients with a diagnosis of MASLD in Sweden between 1987 and 2020. Patients were stratified on co-occurrence of diagnoses of alcohol-related liver disease (ALD) or alcohol use disorder (AUD) prior to MASLD diagnosis. Incident MALOs were derived from national registers. Cox regression was used to calculate hazard ratios (HRs) for incident MALO. RESULTS: A total of 15,107 patients with MASLD were identified. The median age was 55 years, and 52% were female. Of the patients, 1843 (12%) had a prior diagnosis of ALD or AUD. During follow-up, a further 787 patients (5.2%) received a diagnosis of ALD or AUD. Patients with previous ALD or AUD diagnoses at or before baseline had considerably higher rates of MALOs compared with patients without (19.5% vs 7.8%; adjusted HR, 3.12; 95% confidence interval, 2.74-3.55). Acquiring an ALD or AUD diagnosis after MASLD diagnosis was associated with higher rates of MALOs (adjusted HR, 5.81; 95% confidence interval, 4.90-6.88). CONCLUSIONS: ALD or AUD is commonly diagnosed prior to or after MASLD diagnosis. Such patients have considerably higher rates of progression to MALOs. Correctly separating between MASLD and ALD is vital to assess prognosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Nasr P, Wester A, Ekstedt M, et al. Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis. Clin Gastroenterol Hepatol. 2024. PMID: 38237695. doi:10.1016/j.cgh.2024.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。